5.17 %HPV-35 was found in 5.17% of HR-HPV-positive samples.
Gabonhigh-risk human papillomaviruspublished 2025Diseases (Basel, Switzerland)PubMeddocument of 12 observations
Gold tier: mechanically validated evidence, with its primary source.
3,256 evidence items · page 45 / 131
5.17 %HPV-35 was found in 5.17% of HR-HPV-positive samples.
Gabonhigh-risk human papillomaviruspublished 2025Diseases (Basel, Switzerland)PubMeddocument of 12 observations
6.8 %The Loa loa infection rate was 6.8% among HIV-negative participants.
Gabonloasepublished 2022Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 10 observations
55 %Respondents' overall practices toward STH infection were rated as good by 55%.
Gabonsoil-transmitted helminth infectionpublished 2024BMC public healtheurope_pmcdocument of 8 observations
25.5 %HPV-50'S prevalence among HIV-infected women in Ouagadougou was 25.5%.
GabonHPV-50'S · VIH/sidaobserved 2009–2010published 2011Acta tropicaeurope_pmcdocument of 8 observations
97.1 %At day 28, the PCR-adjusted efficacy of amodiaquine-artesunate was 97.1%.
Gabonpaludismepublished 2011PLoS medicineeurope_pmcdocument of 15 observations
67 %Four of the six confirmed hepatitis A breakthrough infections occurred in immunocompromised populations, representing 67%.
Gabonhepatitis Apublished 2025International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 5 observations
47 biopsiesHPV-positive results were detected in 47 biopsies, including 12 cases of CIN2/3 and 35 cases of ICC (4 adenocarcinoma and 31 squamous cell carcinoma).
Gabonadenocarcinoma · ICC · infection à HPV · lésions précancéreuses du col (CIN) · squamous cell carcinomapublished 2025Health science reportsPubMeddocument of 3 observations
70 %Uncorrected adequate clinical and parasitological response (ACPR) in the intention-to-treat set was 70% for artesunate-pyronaridine (AP) at day 42.
Gabonpaludismepublished 2026The Lancet. Microbeeurope_pmcdocument of 21 observations
18.5 %Carcinogenic HPV prevalence was 18.5% among 1,524 women participating in the national 'Octobre Rose' campaigns in Libreville, Gabon.
Gaboncarcinogenic HPVpublished 2025Nature communicationsPubMeddocument of 4 observations
The prevalence of pfmdr1 86Y mutant allele was comparable between 2005 and 2008.
Gabonpaludismeobserved 2005 and 2008published 2014Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 5 observations
6.6 %Vitamin B12 deficiency was found in 6.6% of Gabonese pregnant women at pregnancy diagnosis.
Gabonvitamin B12 deficiencyHAL · Unilimdocument of 71 observations
19.5 %Plasmodium ovale accounted for 19.5% of Plasmodium species identified in malaria cases in Franceville between 2017 and 2019.
Gabonpaludismeobserved 2017-2019published 2023Journal of public health in Africaeurope_pmcdocument of 7 observationsDOI 10.4081/jphia.2023.1865
69 casesSimultaneous aerobic vaginitis–bacterial vaginosis–vulvovaginal candidiasis (AV-BV-VVC) represented 69 cases (25.3%) of mixed infections.
Gabonaerobic vaginitis–bacterial vaginosis–vulvovaginal candidiasispublished 2022International journal of women's healtheurope_pmcdocument of 19 observationsDOI 10.2147/ijwh.s349754
27 %At week 26, positive results were obtained for 22 (27%) of 83 sputum samples with Xpert MTB/RIF.
Gabontuberculoseobserved week 26published 2013The Lancet. Respiratory medicineeurope_pmcdocument of 9 observationsDOI 10.1016/s2213-2600(13)70119-x
37 %17 of 46 samples (37%) harboured multiple genotypes of at least one Plasmodium species.
Gabonpaludismepublished 2017Malaria journaleurope_pmcdocument of 6 observations
63.2 %Among AS heterozygotes, the severe neurological form of malaria had a frequency of 63.2%.
Gabonpaludismeobserved January 2020 to October 2021published 2024International Journal of Contemporary PediatricsOpenAlexdocument of 8 observationsDOI 10.18203/2349-3291.ijcp20243410
1,749 samplesThe frequency of pfdhfr and pfdhps mutations was studied in 1749 samples.
Gabonpaludismeobserved 2014-18published 2023The Lancet. Microbeeurope_pmcdocument of 3 observationsDOI 10.1016/s2666-5247(23)00211-2
43.4 %Among fever episodes in children with sickle-cell disease, bone and joint pain was reported in 43.4% of cases.
Gabondrépanocytosepublished 2014Open Journal of PediatricsOpenAlexdocument of 12 observationsDOI 10.4236/ojped.2014.44036
7.8 %In the study population in Franceville, only 7.8% of households screened their children for sickle cell disease.
GabondrépanocytoseHAL · Unilimdocument of 90 observations
71.8 %Children aged 0–5 years accounted for 71.8% of all severe malaria cases in southeastern Gabon in 2019.
Gabonpaludismeobserved 2019published 2023BMC infectious diseaseseurope_pmcdocument of 14 observations
2.3 %Filariasis due to Mansonella perstans was detected in 2.3% of febrile children (10/428) in Makokou, Gabon.
Gabonfilariasis due to Mansonella perstanspublished 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 16 observations
100 %Packed red blood cells were the only labile blood product transfused, in 100% (n=71) of cases.
Gabondrépanocytosepublished 2025World Journal of Advanced Research and ReviewsOpenAlexdocument of 11 observations
47.9 %Among hospitalised PLHIV with tuberculosis, 47.9% were on antiretroviral therapy.
Gabontuberculose · VIH/sidaobserved 2021-2022published 2025Southern African journal of infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.4102/sajid.v40i1.695
20 yearsAdult Loa loa worms live up to 20 years.
GabonloaseHAL · Unilimdocument of 153 observations
0.5 %Human metapneumovirus (hMPV) was detected in 0.5% of the 156 respiratory virus-positive nasopharyngeal swab specimens collected in Gabon from March 2020 to July 2021.
Gabonhuman metapneumovirusobserved March 2020 to July 2021published 2024Viruseseurope_pmcdocument of 8 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.